SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Apricus Biosciences
An SI Board Since September 2014
Posts SubjectMarks Bans Symbol
2026 18 0 APRI
Emcee:  mokelumne river Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1326Called David Collins this morning to ask about the current royalty numbers we haoldcoach19-6/19/2015
1325Interesting point James, maybe I should call the Vandel-Group for info and use teico20-6/19/2015
1324unless Putin comes to the rescue, or Germany blinks first, definitely a mess thoeico20-6/19/2015
1323Yes, what a mess.mokelumne river-6/18/2015
1322At the end of the month if/when Greece defaults the Euro could get a lot worse aphoenix_rising-6/18/2015
1321Somewhat off topic, I have been curious as to where our Board Chair is going to mokelumne river-6/18/2015
1320makes sense MI, a very large difference in exchange rate from 2011, a good questeico20-6/18/2015
1319M.I.-I really don't remember the time frame of my talk with David Collins onoldcoach19-6/18/2015
1318Old Coach My response to your comment would be: 1- How long ago was that convMirror Image-6/18/2015
1317good point PR, makes sense , so around $50M should be right, considering the beneico20-6/18/2015
1316These numbers are what RPRX spent over 2012-2014 on R&D , so should give a rphoenix_rising-6/17/2015
1315And I am hoping that RayVa Phase 3 is much cheaper.mokelumne river-6/17/2015
1314RPRX did 7 Phase 3 plus 3 extension studies, Fis. should have an easier time thoeico20-6/17/2015
1313M.I.-I am by no means suggesting you are using the wrong figures, but Dave Colloldcoach19-6/17/2015
1312I did some limited research on the Androxal Phase 3 trial. Now there were severmokelumne river-6/17/2015
1311good thinking James, it's interesting that Sarissa owns RPRX as well, Femproeico20-6/17/2015
1310Let's use MI's royalty, say $1.50 per unit to keep it simple. Assume (pmokelumne river-6/17/2015
1309I agree, King Kong ain't got nothin on you, very good figuring MI, it seems eico20-6/17/2015
1308nice work MI, bullish for Vitaros, and I agree on Rayva, so the question is whenMirror Image-6/17/2015
1307good point PR, there's no BS from you mate :)eico20-6/17/2015
1306here's another hint on revs from the new Corp Presentation: "Vitaros reeico20-6/17/2015
1305No point trying to break it down too much yet i think.phoenix_rising-6/17/2015
1304nice work MI, bullish for Vitaros, and I agree on Rayva, so the question is wheneico20-6/17/2015
1303Just taking a look at the newest Corporate Presentation and really wanted to SpoMirror Image-6/17/2015
1302From the presentation: "First Patient Enrolled May 28 – exceeding internalphoenix_rising-6/15/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News